Weekly injection for diabetes and weight loss
Part of Hormones & metabolism clinical trials.
This study tests an experimental once-weekly injection called ribupatide for people with type 2 diabetes and overweight. It aims to help them lose weight and better control their blood sugar.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have type 2 diabetes.
- Your diabetes treatment (diet, exercise, or oral medication) has been stable for the past 3 months.
- Your body mass index (BMI) is 27 or higher.
- You've tried to lose weight with diet or exercise in the last 6 months but it didn't work well.
- You haven't used any weight-loss drugs (like Ozempic, Wegovy, or Mounjaro) in the last 3 months.
- You don't have a history of certain thyroid cancers or pancreatitis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medication, Ribupatide, to see if it helps people with obesity or overweight who also have weight-related health problems. You cannot have diabetes to join.
This trial tests an investigational medication, Enicepatide, to see if it helps people with obesity or overweight and type 2 diabetes lose weight and improve blood sugar control. You will receive weekly injections and regular check-ups.
This trial tests a new once-weekly injection called Ribupatide for weight loss in people with obesity who do not have diabetes. It compares the study drug to an existing medication (semaglutide) and a placebo to see how well it works and if it's safe.
This trial tests a once-weekly injection (tirzepatide) versus a placebo to help people who are obese or overweight with related health conditions lose weight. You may qualify if you have tried to lose weight through diet before, but have not been successful.
This study tests a new injected medicine that may help people with type 2 diabetes and overweight or obesity lose weight. The trial will see how well it works and if it is safe compared to a placebo.
This trial tests an injected medication to help people with obesity and knee osteoarthritis lose weight and improve joint pain. It may be a good option if you have struggled with weight and have knee arthritis.
Hear when a new Obesity With Diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.